human papilloma virus infection
human papilloma virus infection
Explore linked clinical trials. Standard reference: MONDO:0005161173 results · Page 1 of 7
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM | Blood Protein Disorders, DNA Virus Infections, Hemic and Lymphatic Diseases, Hypogammaglobulinemia, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, agammaglobulinemia, common wart, hematologic disorder, human papilloma virus infection, immune system disorder, immunodeficiency disease, inborn error of immunity, lymphatic system disorder, lymphoproliferative syndrome, skin disorder, skin disorder caused by infection, viral infectious disease | Enrolling by invitation | Phase 1 / Phase 2 | 2026-10-09 | NCT07775313 | |
| Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, laryngeal disorder, neoplasm, otorhinolaryngologic disease, recurrent respiratory papillomatosis, respiratory system disorder, respiratory tract neoplasm, sexually transmitted disease, tracheal disorder, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07756840 | |
| Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia | Bacterial Infections and Mycoses, Central Nervous System Fungal Infections, Cryptococcal meningitis, Cytopenia, DNA Virus Infections, Hemic and Lymphatic Diseases, Infections, Neuroinflammatory Diseases, Opportunistic Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, autoimmune disease, central nervous system disorder, central nervous system infectious disorder, common wart, cryptococcosis, fungal infectious disease, fungal meningitis, hematologic disorder, human papilloma virus infection, idiopathic CD4-positive T-lymphocytopenia, immune system disorder, inborn error of immunity, leukocyte disorder, leukopenia, lymphopenia, meningitis, nervous system disorder, skin disorder, skin disorder caused by infection, viral infectious disease | Recruiting | Not stated | 2026-10-08 | NCT00867269 | |
| Feasibility of HPV Testing With Mail-delivered Sample Collection Kits | Blood-Borne Infections, DNA Virus Infections, Disease Attributes, Genital Diseases, HIV infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-10-06 | NCT07087145 | |
| Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression | DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, human papilloma virus infection, infectious disease, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not applicable | 2026-10-05 | NCT07858201 | |
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) | Atypical Squamous Cells of the Cervix, DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Morphological and Microscopic Findings, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions, Tumor Virus Infections, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, human papilloma virus infection, infectious disease, neoplasm, precancerous condition, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not applicable | 2026-10-05 | NCT07762209 | |
| Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-10-01 | NCT04199689 | |
| Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-09-30 | NCT07850128 | |
| Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, common wart, human papilloma virus infection, infectious disease, sexually transmitted disease, skin disorder, skin disorder caused by infection, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 3 | 2026-09-29 | NCT07848100 | |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) | DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervical carcinoma, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, neoplasm, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-09-29 | NCT06498661 | |
| Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not stated | 2026-09-28 | NCT03309033 | |
| Communication Strategies to Increase HPV Vaccinations | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-09-24 | NCT06784960 | |
| Long-Term Immune Persistence After Bivalent HPV Vaccination in Females From Study 311-HPV-1005 | DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, human papilloma virus infection, infectious disease, neoplasm, precancerous condition, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not stated | 2026-09-22 | NCT07833852 | |
| ESCUDDO Long Term Follow Up | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Phase 4 | 2026-09-22 | NCT07706673 | |
| Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 3 | 2026-09-17 | NCT07824310 | |
| Long-term Immune Persistence of a Bivalent HPV Vaccine in Females From Study 311-HPV-1004 | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not stated | 2026-09-17 | NCT07820241 | |
| Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Tumor Virus Infections, Urogenital Diseases, epithelial neoplasm, human papilloma virus infection, infectious disease, neoplasm, papilloma, respiratory system disorder, respiratory tract infectious disorder, sexually transmitted disease, squamous cell neoplasm, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-09-16 | NCT05797246 | |
| Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up | DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, neoplasm, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-09-15 | NCT07807202 | |
| Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts | DNA Virus Infections, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, common wart, human papilloma virus infection, skin disorder, skin disorder caused by infection, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-15 | NCT07806617 | |
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 4 | 2026-09-15 | NCT05672927 | |
| Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-09-14 | NCT04255849 | |
| Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not applicable | 2026-09-14 | NCT03429413 | |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-09-14 | NCT03036930 | |
| People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity | Blood-Borne Infections, DNA Virus Infections, Disease Attributes, Genital Diseases, HIV infectious disease, Head and Neck Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Oral Squamous Cell Carcinoma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Tumor Virus Infections, Urogenital Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, human papilloma virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, neoplasm, oropharynx squamous cell carcinoma, sexually transmitted disease, squamous cell carcinoma, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not stated | 2026-09-11 | NCT06055868 | |
| Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, anogenital human papillomavirus infection, common wart, human papilloma virus infection, infectious disease, sexually transmitted disease, skin disorder, skin disorder caused by infection, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2026-09-10 | NCT07698886 |